Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caleb Lee

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid TumorsShunji Takahashi, Masato Karayama, Masato Takahashi, et al.
The Lancet. Oncology|October 18, 2017
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation studyToshihiko Doi, Kohei Shitara, Yoichi Naito, et al.
Journal of Medical Entomology|August 15, 2014
Feeding host range of Aedes albopictus (Diptera: Culicidae) demonstrates its opportunistic host-seeking behavior in rural SingaporeRelus Kek, H C Hapuarachchi, Chiew-Yuan Chung, et al.
The Lancet. Microbe|February 11, 2024
Efficacy of Wolbachia-mediated sterility to reduce the incidence of dengue: a synthetic control study in SingaporeJue Tao Lim, Somya Bansal, Chee Seng Chong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib StudyShanu Modi, Haeseong Park, Rashmi K Murthy, et al.
The Lancet. Oncology|May 4, 2019
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 studyKenji Tamura, Junji Tsurutani, Shunji Takahashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2020
Reply to T.J.A. DekkerShanu Modi, Haeseong Park, Rashmi K Murthy, et al.
The Lancet. Planetary Health|September 7, 2024
Effectiveness of Wolbachia-mediated sterility coupled with sterile insect technique to suppress adult Aedes aegypti populations in Singapore: a synthetic control studySomya Bansal, Jue Tao Lim, Chee-Seng Chong, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|March 15, 2011
Entomological investigation and control of a chikungunya cluster in SingaporeCheong Huat Tan, Pei Sze Jeslyn Wong, Mei Zhi Irene Li, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Human vascular organoids with a mosaic <i>AKT1</i> mutation recapitulate Proteus syndromeSiyu He, Yuefei Zhu, Shradha Chauhan, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid TumorsShunji Takahashi, Masato Karayama, Masato Takahashi, et al.
The Lancet. Oncology|October 18, 2017
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation studyToshihiko Doi, Kohei Shitara, Yoichi Naito, et al.
Journal of Medical Entomology|August 15, 2014
Feeding host range of Aedes albopictus (Diptera: Culicidae) demonstrates its opportunistic host-seeking behavior in rural SingaporeRelus Kek, H C Hapuarachchi, Chiew-Yuan Chung, et al.
The Lancet. Microbe|February 11, 2024
Efficacy of Wolbachia-mediated sterility to reduce the incidence of dengue: a synthetic control study in SingaporeJue Tao Lim, Somya Bansal, Chee Seng Chong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib StudyShanu Modi, Haeseong Park, Rashmi K Murthy, et al.
The Lancet. Oncology|May 4, 2019
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 studyKenji Tamura, Junji Tsurutani, Shunji Takahashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2020
Reply to T.J.A. DekkerShanu Modi, Haeseong Park, Rashmi K Murthy, et al.
The Lancet. Planetary Health|September 7, 2024
Effectiveness of Wolbachia-mediated sterility coupled with sterile insect technique to suppress adult Aedes aegypti populations in Singapore: a synthetic control studySomya Bansal, Jue Tao Lim, Chee-Seng Chong, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|March 15, 2011
Entomological investigation and control of a chikungunya cluster in SingaporeCheong Huat Tan, Pei Sze Jeslyn Wong, Mei Zhi Irene Li, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Human vascular organoids with a mosaic <i>AKT1</i> mutation recapitulate Proteus syndromeSiyu He, Yuefei Zhu, Shradha Chauhan, et al.
Pageof 3